Losartan for Patients With COVID-19 Not Requiring Hospitalization

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a multi-center, double-blinded study of COVID-19 infected patients randomized 1:1 to daily losartan or placebo for 10 days or treatment failure (hospital admission).
Epistemonikos ID: 5e335fc7e49acd8450e59e36af731b38ad484fd5
First added on: Mar 31, 2020